GINZA NOA CLINIC
Tokyo, Japan International Patient Support
Contact Us

How Long Can Stem Cells Be Stored?

Properly cryopreserved blood-forming stem cells can remain usable for years to decades. A retrospective study of 288 cord-blood transplants found no association between storage duration, which ranged up to 11.07 years, and the measured recovery or engraftment outcomes. A separate cord-blood bank validated storage for up to 29 years for one processing method. Neither finding establishes a universal expiry date for all stem cells. 25262882PMC10785215

The useful answer for your own cells depends on the cell type, processing method, storage conditions, and the bank’s validated expiry. Frozen storage and the period after thawing are different: a product that can be stored for decades may have only a short preparation-to-infusion window.

How Long Can Stem Cells Be Stored?

Storage time by method

For one FDA-licensed cord-blood product, the instructions require storage at or below −150°C until thawing and preparation. This is a product-specific requirement, not a universal temperature rule for every stem-cell product. Download Duke’s Carolinas Cord Blood Bank states that its cord-blood units can be stored for at least two decades, and perhaps longer, under its liquid-nitrogen procedures. That statement is not an expiry certificate for a unit held elsewhere. Storing cord blood

Storage situation What duration is supported? What to check
Fresh or refrigerated, never frozen No universal duration established by the evidence reviewed here The exact product’s collection-to-use limit and transport instructions; do not apply frozen-storage figures
Frozen at −80°C No general multi-year expiry established by the sources used here Written validation for the exact cell product, freezer conditions, and intended storage period
Long-term cryogenic storage of blood-forming cells Clinical cord-blood data include storage beyond 10 years; one bank validated up to 29 years for a specific processing method. 25262882PMC10785215 Your bank’s method-specific expiry and temperature requirements
Thawed cord blood prepared for infusion One FDA insert allows holding at 4–8°C for up to 30 minutes without DMSO removal, or up to four hours after DMSO removal, under its specified preparation instructions. Download?attachment The treating team must follow the actual product’s instructions; these times are not transferable to other products

DMSO is the cryoprotectant addressed in those preparation instructions. The two holding times describe different preparation procedures, not a choice a patient should make. Collection, processing at a cell processing center, storage, and release are separate stages to clarify when reviewing the treatment process.

What long-term studies actually show

The studies below concern hematopoietic, or blood-forming, cells from cord blood or peripheral blood. They do not establish storage limits or treatment benefits for mesenchymal, adipose-derived, dental-pulp, or expanded-cell products. A laboratory test after thawing is also not the same as a successful transplant.

Cord blood stored for about 10 years

The U.S. retrospective study examined 288 single cord-blood units transplanted from 1992 to 2013. Storage ranged from 0.08 to 11.07 years. Researchers found no association between storage duration and total nucleated-cell recovery, viability, or neutrophil and platelet engraftment. This supports use under the studied conditions, but an observational study cannot guarantee the outcome of any individual unit. 25262882

A Japanese laboratory study compared 18 cord-blood units stored for 10 years with 18 stored for one month. Mean post-thaw viability in the 10-year group was 83.69%. Differences in recovery of total nucleated cells, CD34-positive cells, and granulocyte–macrophage colonies were not statistically significant. The small study measured laboratory quality, not patient outcomes; a nonsignificant difference does not prove that the groups were equivalent. 21207212

Method-specific validation up to 29 years

The José Carreras Cord Blood Bank in Düsseldorf reported validated expiry periods of 29 years for unseparated units, 25 years for manually volume-reduced units, and 18 years for automatically volume-reduced units. These were different processing groups, not three interchangeable expiry options. PMC10785215

The bank held 21,215 active units as of May 2023; that inventory was not the number tested after 29 years. The 29-year stability analysis used 11 samples. The paper also examined released-transplant data, but noted low sample numbers among the longest-stored units used for transplantation. Its findings support that bank’s validation program, not a promise that every cord-blood unit remains suitable for 29 years. PMC10785215

Peripheral-blood grafts stored for 10 years

A Czech study compared fresh, non-cryopreserved grafts (12 samples), grafts stored for about three months (12 samples), and grafts stored for about 10 years (20 samples). CD34-positive cell viability was preserved, but a clonogenic assay showed reduced ATP production in the long-stored group. In other words, a high proportion of living cells did not mean that every functional measurement was unchanged. PMC8327011

The study concerned grafts in an autologous transplantation setting for lymphoma and multiple myeloma. The authors advised checking graft quality before infusion after storage beyond 10 years, especially when CD34-positive cell numbers are low. These were laboratory assessments, not proof of equal treatment outcomes after every storage duration. PMC8327011

Research samples stored beyond 20 years

A Swedish study assessed 30 CD34-positive hematopoietic stem/progenitor-cell grafts stored for up to 34 years. Several viability and functional measures were lower in the group stored for at least 20 years, although some colony-forming capacity remained. The authors could not establish a firm maximum storage time. This small research collection does not demonstrate that 34-year-old grafts reliably work in patients. 41071160

Why the expiry date is not a treatment guarantee

Viability measures how many cells are alive by a particular test. Potency tests assess relevant biological function. Neither result alone establishes that a stored unit contains an adequate dose or is suitable for a particular patient. The Düsseldorf report notes that no single assay is universally accepted to predict engraftment potential. PMC10785215

When reviewing storage arrangements, ask how the bank handles temperature excursions, equipment failures, contamination concerns, identity discrepancies, and transport. These are questions about preserving and documenting quality. A low starting cell dose or missing release documentation may limit suitability even when the cells have not reached their storage expiry.

Regulatory status is a separate question. In the United States, cord-blood products for unrelated recipients require FDA approval or use under an investigational new drug application. Some products intended for the donor or specified relatives do not require premarket approval when the applicable criteria are met. FDA registration of a bank is not FDA endorsement or proof that its services are effective. These U.S. requirements should not be assumed to apply in Japan. Cord blood banking information consumers

For services in Japan, ask separately about registration and compliance documentation and the evidence for the proposed treatment. A filing or facility certificate does not, by itself, demonstrate clinical efficacy. Storage research on blood-forming cells cannot validate a clinic’s anti-aging, joint, or cosmetic treatment claims.

How to check your own storage agreement

Ask for the expiry attached to your exact unit or product, not the oldest storage figure in a brochure. The Düsseldorf study provides a concrete reason: its validated periods differed by processing method. A headline saying “up to 29 years” leaves out which method qualified. PMC10785215

A practical paperwork check

Suppose a brochure advertises 29-year storage, but your agreement does not name the processing method or state an expiry. This is an illustrative document-review scenario, not a patient case. Ask the bank to identify the method, provide the validation applicable to your product, and confirm the expiry in writing. Do not assume that a finding for unseparated cord blood applies to expanded adipose-derived cells.

Next, compare three documents: the collection or processing record, the storage agreement, and the proposed release requirements. Check that the unit identifier and cell source agree across them. Ask the bank to explain missing or inconsistent information before signing or arranging a transfer.

  • Product identity: What cells were collected, how were they processed, and which unit identifier follows them through storage and release?
  • Validated duration: What expiry applies, from which starting date is it calculated, and what evidence supports an extension?
  • Storage and transport: What temperatures are required, how are they monitored, and what happens after an excursion or equipment failure?
  • Release testing: Which identity, quality, viability, and potency checks apply, and who decides whether the unit can be released?
  • Use after thawing: What preparation-to-infusion limit applies to this exact product, and who coordinates it with the treating team?
  • Contract terms: What do storage fees cover, what costs extra, and what happens if you transfer banks, stop paying, or request disposal? Separate storage charges from any proposed treatment costs.

“How long can you keep the cells?” and “Will this unit be suitable for my treatment?” are different questions. Ask the bank for the validated storage period and the treating team for an assessment of the proposed use.

Can stem cells be stored indefinitely?

The evidence reviewed here does not establish an unlimited storage life. It includes a method-specific cord-blood validation of 29 years and laboratory research on grafts stored for up to 34 years, with limitations and signs of decline in some measures. Those findings cannot establish a lifetime guarantee. PMC1078521541071160

For a practical decision, use the expiry validated for your exact product and ask what testing is needed before release. Years to decades may be supported for certain cryopreserved blood-forming cells; the same figure should not be assigned to every cell type or to a thawed product. This article provides general information, not an assessment of an individual unit or personal medical advice.

Reviewing cell-storage arrangements in Japan?

Ask which expiry, monitoring, and release requirements would apply to your proposed storage arrangement.

Contact the inquiry desk

References

  1. Mitchell et al.: cryopreservation duration and outcomes in 288 single cord-blood transplants
  2. Liedtke et al.: long-term stability and method-specific expiry at the José Carreras Cord Blood Bank
  3. FDA: HPC Cord Blood prescribing information and storage requirements
  4. Duke Carolinas Cord Blood Bank: storing cord blood
  5. FDA: cord-blood preparation and post-thaw holding instructions
  6. Yamamoto et al.: laboratory quality of cord blood stored for 10 years
  7. Lysak et al.: peripheral-blood graft quality after long-term cryopreservation
  8. Axelsson-Robertson et al.: hematopoietic grafts cryopreserved for up to 34 years
  9. FDA: cord blood banking information for consumers